Holista CollTech Ltd (ASX: HCT) Share Price and News

Mr Kin, a Singaporean, has nearly 40 years' experience in international journalism, investment banking and communications. He has worked as a foreign correspondent in Singapore, Beijing, New Delhi and Kuala Lumpur (where he was Chief Correspondent for Malaysia and Brunei for Reuters). After a decade in journalism, he joined Merrill Lynch as head of equity research for Malaysia for the U.S. investment bank. In 1999, he founded the WeR1 group, which offers consultancy services for investor relations, including IPOs, and crisis communications. He has handled corporate crisis situations in Asia and is consulted by business leaders for corporate strategy.

Mr. Loong brings experience in corporate management, financial oversight, and business development. His track record includes driving operational improvements and delivering results in environments. He is an entrepreneur and inventor with 30 years in: Nanotechnology Green Chemistry, and Environmental Technology. He holds patents and has contributed to advancements in air purification, environmental sustainability, and material recycling across several global industries. Currently, Mr. Leong also serves as the Executive Chairman of the Malaysia-headquartered SHEPROS Group of Companies, where he continues to lead projects that align with the latest in environmental and technological developments.

Mr. Pilant is the founder, CEO, and Chairman of Regenerex Pharma, Inc., which is listed on the OTCB in the United States as well as several other private companies. An entrepreneur, he established Greystone Pharmaceuticals, Inc., and has led medical and pharmaceutical firms since 1985, including Stanley Pharmaceuticals, National Labs, and MedStat. With over 30 years of experience in wound care, Mr. Pilant has been in setting up manufacturing facilities across the United States, China, Europe, and the Middle East. His experience spans FDA and CE compliance, reimbursement, manufacturing, and distribution.

Mr. Yee has held roles in multinational organisations, in pharmaceuticals, diagnostics, and wellness. As CEO of Gribbles Diagnostic, he achieved revenue and profit growth over three years by re engineering the organization and improving staff productivity. At Wyeth, he doubled sales between 2007 and 2009 and introduced impactful CSR initiatives such as Wyeth Aid. At Pfizer, he managed the COX-2 drug withdrawal crisis and, as Asia Pacific Marketing Director, refined regional business plan. His roles at Merck Serono, Beacon International, and Envy Continent (a wellness tourism venture he founded) underscored versatility in business model implementation and strategic articulation. Earlier, at GlaxoSmithKline and Roche, he secured government tenders and elevated brands to market leadership.

Mr. Gemelli is an entrepreneur and business operator with a track record across multiple industries. He began his career in the insurance sector at Federation Insurance, rising to a management position. Transitioning to the entertainment industry, he collaborated with Entertainment Enterprises Pty Ltd, eventually becoming General Manager of the Group. He later established his own entertainment business in Broome, Western Australia, which he sold at a profit.

-

-